CRON Stock Forecast: Cronos Signs $122-Million Deal to Produce Lab-Grown Cannabis

iStock.com/PhotoBylove CRON Stock Forecast Cronos Group Inc (NASDAQ:CRON) is looking to take pot out of the ground and into the lab, signing a $122.0-million deal with Ginkgo Bioworks Inc. to genetically engineer the active compounds found [...]
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.